Metalyse 5 000 units (25 mg) powder for solution for injection
APHP240911
Phase 3 small_molecule active
Quick answer
Metalyse 5 000 units (25 mg) powder for solution for injection for Adult patients with a LVOS with large core within 9 hours of symptoms onset or last seen well, or with a diffusion weighted imaging (DWI)-fluid attenuated inversion recovery (FLAIR) mismatch in case of unknown onset. is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adult patients with a LVOS with large core within 9 hours of symptoms onset or last seen well, or with a diffusion weighted imaging (DWI)-fluid attenuated inversion recovery (FLAIR) mismatch in case of unknown onset.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active